Researchers from the Cluster of Excellence “CUI: Advanced Imaging of Matter” have achieved a breakthrough—creating a completely new type of plasma by combining state-of-the-art technologies using ultrashort laser pulses and ultracold atomic gases. They report on a novel electron cooling mechanism occurring in such plasmas in the journal Nature Communications.
An Israeli drug that has been successful in initial trials, could hold a key in blunting the COVID-19 pandemic. Thirty patients in serious condition participated in the trial and all recovered, most of them in less than a week. Sonya Cohen was one of them and she could one day be seen as a walking #miracle.
Follow Jerusalem Dateline and download the CBN News app to ensure you keep receiving news from a Christian Perspective. go.cbn.com/cbnapp.
#covidcure #Israel #Israeli #innovation #fightcovid #breakthrough.
Ichilov Hospital, Tel Aviv
These two high-quality, fully rigged sample characters represent the current state of the art for real-time digital humans and they’re yours to explore, modify, and use in your Unreal Engine 4.26.1 or later projects. They serve as a showcase of what’s achievable with MetaHuman Creator: an innovative new tool that will soon be available for you to create your own MetaHumans—in minutes.
Find out more at http://www.unrealengine.com/digital-humans.
A team of Australian researchers believe they have taken a significant step towards unlocking the regenerative power of the stem cells in our bodies.
2 things I like here. 1. Aubrey says not only does he think the first person to live to 1000 may be alive today but that they are already middle aged(Like me!). 2. In 15 years we might give a 70 year old treatment that will not make them 20 again, but perhaps it will make them 40. then by the time they hit 70 again the treatments available will be even better.
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501©(3) biomedical research charity that performs and funds laboratory research dedicated to combating aging. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40–50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public. Topics Discussed: Brief overview of SENS
- Why try to end aging?
- How soon do you think we will end aging?
- What role does rejuvenation biotech play in the COVID-19 pandemic? How would regenerative medicine help us better cope with the pandemic?
- How are you implementing the techniques you research in your own life?
- Which breakthrough are you most proud of?Aubrey’s Links: LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b/
Personal Website: https://www.sens.org/
Company Website: https://www.mfoundation.org/
Twitter: https://twitter.com/aubreydegreyListen to the audio version at: https://www.buzzsprout.com/765170/7722976-dr-aubrey-de-grey-…e-agingYou can listen to the audio and read the transcript here: https://podcast.boomerliving.tv/dr-aubrey-de-grey-what-cause…-aging/You can listen to many other audio podcasts on our website and Apple Podcasts: https://podcast.boomerliving.tv/
https://podcasts.apple.com/us/podcast/boomer-living-senior-l…1455929808
It’s too early to call it a miracle cure, but if the conclusions from a recent Phase 1 trial for a new drug called EXO-C24 are backed up in subsequent trials, we might have the first true breakthrough therapy for COVID-19. That’s in addition to coronavirus vaccines, of course, which will help prevent severe COVID-19 cases and deaths, and even reduce the spread of the illness. But while vaccines can give the immune system a heads-up to the threat it might have to deal with — the real virus — they have a few limitations. First of all, they don’t work on infected people. Secondly, vaccine supply is still limited and vaccinations aren’t available to anybody who might want one. Then there’s the threat of coronavirus mutations that might reduce vaccines’ effect on the virus and extend the pandemic.
New research shows that patterns inspired by lobster shells can make 3D printed concrete stronger, to support more complex and creative architectural structures.
Digital manufacturing technologies like 3D concrete printing (3DCP) have immense potential to save time, effort and material in construction.
They also promise to push the boundaries of architectural innovation, yet technical challenges remain in making 3D printed concrete strong enough for use in more free-form structures.
A breakthrough skin-gel is showing promising signs in Australian trials, with the ability to halt chronic pain in its tracks, halve healing time and even turn back the clock on ageing skin.
The gel, which is known as RM191A, is believed to be a new class of anti-inflammatory.
It’s a copper-based compound which is applied directly to the skin as a topical.
Posted in biological, biotech/medical, ethics, food, futurism, health, innovation, science, sustainability
In the words of the book’s author, Benjamin Aldes Wurgaft, Meat Planet: Artificial Flesh and the Future of Food (2019) is “not an attempt at prediction but rather a study of cultured meat as a special case of speculation on the future of food, and as a lens through which to view the predictions we make about how technology changes the world.” While not serving as some crystal ball to tell us the future of food, Wurgaft’s book certainly does serve as a kind of lens.
Our very appetites are questioned quite a bit in the book. Wondering about the ever-changing history of food, the author asks, “Will it be an effort to reproduce the industrial meat forms we know, albeit on a novel, and more ethical and sustainable, foundation?” Questioning why hamburgers are automatically the default goal, he points out cultured meat advocates should carefully consider “the question of which human appetite for meat, in historical terms, they wish to satisfy.”
We’re witnessing the emergence of something called “augmented creativity,” in which humans use AI to help them understand the deluge of data.
Researchers at Carnegie Mellon developed an alternate method: an AI-based approach to mining the patent and research databases for ideas that could be combined to form interesting solutions to specific problems. Their system uses analogies to help connect work from two seemingly distinct areas, which they believe makes innovation faster and a lot cheaper.
Augmented creativity
What we’re witnessing is the emergence of something called “augmented creativity,” in which humans use AI to help them understand the deluge of data. Early prototypes highlight the important role humans can, and should, play in making sense of the suggestions proposed by the AI.
